Association between a history of comorbidities and the use of complementary and alternative medicine to prevent COVID-19

Descripción del Articulo

Objective: To evaluate the association between a history of comorbidities and the use of complementary and alternative medicine (CAM) to prevent COVID-19 in Lambayeque, Peru. Material and Methods: Analytical cross-sectional study that used information from the database of the Red Prestacional Lambay...

Descripción completa

Detalles Bibliográficos
Autores: Herrera-Añazco, Percy, Toro-Huamanchumo, Carlos J., Nuñez-Tarazona, Wander, Farfán-Zapata, Olenka
Formato: artículo
Fecha de Publicación:2024
Institución:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Repositorio:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Lenguaje:español
OAI Identifier:oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/2046
Enlace del recurso:https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2046
Nivel de acceso:acceso abierto
Materia:Terapias Complementarias
Medicina Tradicional
Plantas Medicinales
Infecciones por Coronavirus
Prevención Primaria
Complementary Therapies
Medicine Traditional
Plants Medicinal
Coronavirus Infections
Primary Prevention
Descripción
Sumario:Objective: To evaluate the association between a history of comorbidities and the use of complementary and alternative medicine (CAM) to prevent COVID-19 in Lambayeque, Peru. Material and Methods: Analytical cross-sectional study that used information from the database of the Red Prestacional Lambayeque of the Social Security of Health. The outcome variable was the self-report of having consumed and/or used some type of MAC during the pandemic to prevent COVID-19. The main independent variable was the self-reported history of having any comorbidity. Sociodemographic and clinical confounding variables were included. To assess the association of interest, crude (PRc) and adjusted (PRa) prevalence ratios were calculated using Poisson regression models with robust variances. Results: A total of 243 participants with a history of COVID-19 were surveyed. Most were male (54.7%), and the median age was 29 [25-59] years. 29.2% used CAM to prevent COVID-19. In the adjusted model, a history of comorbidity increased the probability of CAM use (PR: 1.55; 95% CI: 1.05 – 2.28; p: 0.028). Conclusions: A history of comorbidity was associated with a higher probability of CAM consumption during the COVID-19 pandemic in adults to prevent SARS-CoV-2 infection.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).